SUSMED,Inc.
Tokyo Stock Exchange 4263.T
SUSMED,Inc. Revenue Per Share for the year ending June 30, 2024: USD 0.13
SUSMED,Inc. Revenue Per Share is USD 0.13 for the year ending June 30, 2024, a -42.99% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
SUSMED,Inc. Revenue Per Share for the year ending June 30, 2023 was USD 0.22, a 41.04% change year over year.
-
SUSMED,Inc. Revenue Per Share for the year ending June 30, 2022 was USD 0.16, a 95.62% change year over year.
-
SUSMED,Inc. Revenue Per Share for the year ending June 30, 2021 was USD 0.08, a 290.92% change year over year.
-
SUSMED,Inc. Revenue Per Share for the year ending June 30, 2020 was USD 0.02.
Key data
| Date | Revenue Per Share | Dividend Per Share | Free Cash Flow Per Share | Return on Assets (ROA) |
|---|
Market news
Loading...
Tokyo Stock Exchange: 4263.T
| CEO | Mr. Taro Ueno |
| IPO Date | Dec. 24, 2021 |
| Location | Japan |
| Headquarters | MFPR Nihonbashi honcho Bldg |
| Employees | 39 |
| Sector | Health Care |
| Industries | |
Description
SUSMED,Inc. develops and sells therapeutic applications in Japan. It develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. The company also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, it offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email